Thalys(SH:603716)2020-04-29 16:00Financial Performance - Operating revenue decreased by 21.80% to CNY 281,472,317.63 compared to the same period last year[5] - Net profit attributable to shareholders was a loss of CNY 22,781,153.99, compared to a profit of CNY 22,021,805.97 in the previous year[5] - Basic and diluted earnings per share both reported at CNY -0.12, down from CNY 0.11 in the previous year[5] - The company's revenue for Q1 2020 was CNY 28,147.23 million, a decrease of 21.80% compared to Q1 2019, primarily due to the impact of the COVID-19 pandemic[13] - Net profit for Q1 2020 was a loss of CNY 2,714.31 million, compared to a profit of CNY 2,496.90 million in Q1 2019, significantly affected by decreased sales and donations made during the pandemic[14] - The company's operating revenue for Q1 2020 was ¥97,315,202.87, a decrease of 49.3% compared to ¥192,166,331.27 in Q1 2019[28] - The net profit for Q1 2020 was a loss of ¥27,143,075.84, compared to a profit of ¥24,969,040.31 in Q1 2019, indicating a significant decline in profitability[27] - The total profit for Q1 2020 was a loss of ¥34,156,495.07, contrasting with a profit of ¥33,247,525.35 in the same period last year[26] - The company's operating profit for Q1 2020 was a loss of ¥23,544,439.65, compared to a profit of ¥34,188,842.52 in Q1 2019[26] Cash Flow and Liquidity - Net cash flow from operating activities improved to a loss of CNY 79,571,848.31, compared to a loss of CNY 87,951,292.41 in the same period last year[5] - The company's cash flow from operating activities for Q1 2020 was a net outflow of CNY 7,957.18 million, an improvement from a net outflow of CNY 8,795.13 million in Q1 2019[16] - The cash flow from operating activities in Q1 2020 was ¥252,713,992.13, down from ¥390,647,837.39 in Q1 2019, reflecting a decrease of 35.3%[30] - The net cash flow from operating activities for Q1 2020 was -99,580,992.99 RMB, compared to -91,175,820.78 RMB in Q1 2019, indicating a decline in operational performance[34] - The total cash inflow from financing activities was 551,800,000.00 RMB in Q1 2020, significantly higher than 238,000,000.00 RMB in Q1 2019, reflecting increased borrowing[32] - The net cash flow from financing activities for Q1 2020 was 216,246,678.06 RMB, compared to 133,697,769.68 RMB in Q1 2019, showing improved financial management[32] - Cash and cash equivalents increased to CNY 431,533,239.39 as of March 31, 2020, compared to CNY 354,774,361.33 at the end of 2019, representing a growth of 21.6%[22] Assets and Liabilities - Total assets increased by 6.71% to CNY 3,208,848,946.41 compared to the end of the previous year[5] - The company reported a total liability of CNY 1,509,186,323.19, compared to CNY 1,324,941,744.29 in the previous year, reflecting an increase of 13.9%[23] - Total liabilities reached CNY 1,386,004,309.83, with non-current liabilities at 65,896,912.39, including long-term borrowings of CNY 50,000,000.00[39] - The equity attributable to shareholders was CNY 1,290,037,049.68, a slight decrease from CNY 1,307,344,825.80 in the previous year[24] - Total assets reached CNY 2,799,223,372.87, an increase from CNY 2,632,286,570.09 at the end of 2019, indicating a growth of 6.4%[23] Shareholder Information - The total number of shareholders reached 15,791 by the end of the reporting period[10] - The largest shareholder, Tianjin Ruimei Scientific Instrument Co., Ltd., holds 40.06% of the shares, amounting to 82,183,492 shares[10] Government Support and Donations - The company received government subsidies amounting to CNY 228,000, while other non-operating income and expenses included a donation of CNY 10,612,055.42 for pandemic-related materials[8] - The company made donations totaling CNY 11 million during the pandemic, impacting its financial performance in Q1 2020[14] Future Outlook - The company is focusing on improving its financial performance and exploring new market opportunities in the upcoming quarters[5] - The company plans to focus on market expansion and new product development to improve future performance[25]